Dr. Philippe Gailloud is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, Department of Neurology and Department of Neurological Surgery. Among his main areas of specialization are the development of interventional techniques, the percutaneous treatment of brain, spinal cord, and spine lesions, and the anatomy and embryology of the cerebral vasculature. Besides the diagnosis and treatment of cerebrovascular diseases in adult patients, Dr. Gailloud also focuses on the management of neurovascular disorders in children. Dr. Gailloud received his medical degree from the University of Geneva, Switzerland, in 1991, and completed his residency in diagnostic and interventional radiology at Geneva University Hospital in 1998. He completed a research fellowship in morphology at the University of Geneva in 1994, and clinical fellowships in diagnostic and interventional neuroradiology at Johns Hopkins. He joined the Johns Hopkins faculty in 2000. Dr. Gailloud has published more than 250 peer-reviewed scientific publications and 25 book chapters on a wide range of topics related to diagnostic and interventional neuroradiology. Dr. Gailloud is rated as an Elite provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Arteriovenous Malformation, Brain Aneurysm, Stroke, Stent Placement, and Liver Embolization.

Judy Huang is a Neurosurgery provider in Baltimore, Maryland. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Trigeminal Neuralgia, Arteriovenous Malformation, Subdural Hematoma, Rhizotomy, and Microvascular Decompression. Dr. Huang is currently accepting new patients.

Dr. Caplan specializes in the treatment of cerebrovascular disorders of the brain, head, neck and spine, such as aneurysms, arteriovenous malformations, arteriovenous fistulas, moyamoya disease, carotid artery stenosis and stroke. He is dual fellowship trained in both open cerebrovascular neurosurgery and endovascular neurosurgery, allowing him to offer patients the full spectrum of the latest surgical and endovascular techniques in treating these diseases. Dr. Caplan also focuses on treating acoustic neuromas and other tumors of the skull base, including meningiomas. Dr. Caplan graduated with honors from the Johns Hopkins University with a degree in neuroscience, where he spent time in the Hunterian Neurological Surgery Research Laboratory. He then earned his medical degree from Harvard Medical School. He completed his neurosurgery residency at Johns Hopkins, along with fellowships in cerebrovascular neurosurgery and endovascular neurosurgery, also at Johns Hopkins. He then completed an additional fellowship in endovascular neurosurgery at the University of Miami before returning to join the Johns Hopkins faculty. Dr. Caplan is rated as a Distinguished provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Brain Aneurysm, Arteriovenous Malformation, Cerebral Arteriovenous Malformation, Thrombectomy, and Carotid Artery Surgery.

Dr. Tamargo specializes in the treatment of aneurysms, arteriovenous malformations (AVMs), arteriovenous fistulas (AVFs), and cavernous malformations of the brain and spinal cord in both adults and children. Dr. Tamargo specializes in revascularization procedures for moyamoya disease. For this condition, Dr. Tamargo performs either a microsurgical encephaloduroarteriomyosynangiosis (EDAMS) or a microsurgical extracranial-to-intracranial artery bypass. Dr. Tamargo also specializes in the treatment of acoustic neuromas (vestibular schwannomas). A recipient of numerous honors and awards, some of Dr. Tamargo's most recent accolades include the Neurosurgery Faculty Teaching Award and the Hopkins Richard S. Ross Clinician Scientist Award. Dr. Tamargo is rated as a Distinguished provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, and Schwannoma.

Dr. Clifford Weiss is a Professor of Radiology and Radiological Science. He also holds appointments in Surgery and Biomedical Engineering. Additionally, he serves as Medical Director of the Johns Hopkins Center for Bioengineering Innovation and Design (CBID), the Director of the Johns Hopkins HHT Center of Excellence as well as Director of the Johns Hopkins Vascular Anomalies Center. Dr. Weiss' clinical focus lies in vascular and interventional radiology with a particular focus on the diagnosis and treatment of vascular malformations. This includes venous and lymphatic malformations, arteriovenous malformations, pulmonary arteriovenous malformations and Hereditary Hemorrhagic Telangiectasia (HHT) and varicoceles. Dr. Weiss also is a pioneer in the use of MRI for interventional guidance (iMRI), especially for the treatment of vascular malformations. Dr. Weiss' research focuses primarily on the preclinical and clinical development of Bariatric Embolization, a new endovascular procedure designed to help fight obesity, and on the development of new embolic therapies and devices. Dr. Weiss is the Deputy Editor of Interventional Content for the journal Radiology. Dr. Weiss received his B.A. from Dartmouth College in 1995, his M.D. from the Johns Hopkins University School of Medicine in 2001. He completed an internship in internal medicine on the Osler Service in 2002, his residency in Diagnostic Radiology in 2007, and a Fellowship in Vascular and Interventional radiology in 2008, all at The Johns Hopkins Hospital. He is a Fellow both of the Society of Interventional Radiology (SIR) and of Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Pulmonary Arteriovenous Malformation (PAVM), Pulmonary Arteriovenous Fistula, Arteriovenous Malformation, Liver Embolization, and Embolectomy.

L. Fernando Gonzalez, M.D., is a cerebrovascular neurosurgeon trained in both open vascular surgery and minimally invasive endovascular approaches. He treats patients with vascular blockages, malformations and ruptures in the brain and spine, including aneurysms, strokes and arteriovenous malformations. He also specializes in delivering chemotherapy through the arteries of the brain for treatment of certain eye cancers, such as retinoblastomas — the most common eye cancer in children — and lacrimal gland carcinomas. Dr. Gonzalez sees patients at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. Dr. Gonzalez earned his medical degree from Pontificia Universidad Javeriana in Bogota, Colombia, where he also completed residency training in neurosurgery. He completed a neurosurgery research fellowship at Barrow Neurological Institute in Phoenix, Arizona, with a focus on skull base, vascular and microanatomy microsurgery. Dr. Gonzalez continued his training at Barrow by completing a second residency, during which he pursued additional fellowships in spine surgery, endovascular neurosurgery, and cerebrovascular and skull base surgery. Dr. Gonzalez is widely published in his field and actively pursues novel approaches to treatment. He invented an aspiration catheter with an attached guidewire, and a surgical retractor for minimally invasive brain surgery. He is also a co-inventor of a direct cerebral cooling device that allows clinicians to decrease cerebral temperature to protect the brain when needed after cardiac arrest, severe trauma or large strokes. Videos Meet Our Expert: L. Fernando Gonzalez, M.D.Cerebrovascular Neurosurgery. Dr. Gonzalez is rated as an Advanced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Brain Aneurysm, Subarachnoid Hemorrhage, Stroke, Stent Placement, and Transmyocardial Revascularization.

Dr. Hicks specializes in congenital aortic pathologies including aberrant subclavian arteries and aortic coarctation, thoracic and abdominal aortic aneurysms, complex lower extremity revascularization including lower extremity bypasses and stenting, and carotid endarterectomy. She is skilled in both open and endovascular surgery for the treatment of aortic and peripheral disease. She is also accomplished in clinical research with over 130 peer-reviewed publications and numerous textbook chapters; her research interests include clinical outcomes in aneurysm repair and lower extremity revascularization, as well as high-value care in vascular surgery. A distinguished fellow of the American Board of Surgery, Dr. Hicks is the recipient of the Department of Surgery Rothman Early Career Development Award for Surgical Research and was selected as a Visiting Scholar to the American Board of Medical Specialties for 2018-2019. She is also an appointed member of a CMS Clinical Expert Subcommittee tasked with refining peripheral vascular disease cost measures for implementation in the Quality Payment Program. LinkedIn https://www.linkedin.com/in/caitlin-hicks-b211b617/. Dr. Hicks is rated as an Advanced provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Carotid Artery Disease, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Aneurysm Repair.

Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds faculty appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research program aims to advance equity in kidney disease and hypertension outcomes by focusing on social drivers of health inequities. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award--a $250,000 award granted to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. In 2019, Dr. Crews received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians and the Distinguished Leader Award from the American Society of Nephrology. Dr. Crews is the founding director of the Doctoral Diversity Program, a 2-year, research-intensive post-baccalaureate program of the Johns Hopkins Initiative for Careers in Science and Medicine. Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins. Dr. Crews is rated as an Advanced provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Arteriovenous Malformation, Kidney Transplant, and Nephrectomy.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery.

Risheng Xu, M.D., Ph.D., is a fellowship-trained neurosurgeon with expertise in cerebrovascular and endovascular neurosurgery, and skull base pathologies. He treats patients with a wide range of cerebrovascular disorders such as cerebral aneurysms, subarachnoid hemorrhage, arteriovenous malformations, arteriovenous fistulas, carotid stenosis, cavernous malformations and moyamoya disease. He also treats skull base tumors such as acoustic neuromas (vestibular schwannomas) and meningiomas, and pain disorders such as trigeminal neuralgia. Dr. Xu completed his undergraduate studies at Harvard College, and attended medical school at the Johns Hopkins University School of Medicine, where he also obtained a Ph.D. in pharmacology and molecular sciences. He continued his residency training in neurosurgery at Johns Hopkins, and remained there to complete a fellowship in cerebrovascular and endovascular neurosurgery. Dr. Xu has been active in research throughout his training and has authored and co-authored numerous published studies. His basic science research endeavors focus on neuroinflammation after ischemic stroke and molecular mechanisms underlying trigeminal neuralgia. He has authored or co-authored over 100 manuscripts, and has published in journals such as Nature, Nature Communications, Science Advances, Science Signaling, Neuron, the Proceedings of the National Academy of Sciences (PNAS), the Journal of Neurosurgery, Neurosurgery and other journals. Clinically, he studies the long-term outcomes of patients with cerebrovascular disorders and trigeminal neuralgia. Dr. Xu is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Brain Aneurysm, Subarachnoid Hemorrhage, Stroke, Transmyocardial Revascularization, and Stent Placement.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Hydrocephalus, Chiari Malformation, Chiari Malformation Type 2, Posterior Fossa Decompression, and Endoscopy.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.

Bardia Nourbakhsh, M.D., M.A.S., is an associate professor of neurology at Johns Hopkins University School of Medicine. He practices out of The Johns Hopkins Hospital in Baltimore, Maryland. Dr. Nourbakhsh has expertise in multiple sclerosis (MS) and neuroimmunology. Dr. Nourbakhsh earned his medical degree from the Tehran University School of Medical Sciences and completed a residency in neurology at the University of Texas Southwestern Medical Center. He studied epidemiology, study design, and biostatistics, obtaining a Master of Advanced Studies degree in clinical research from the University of California, San Francisco School of Medicine, where he also completed a fellowship in MS and neuroimmunology. In 2014, Dr. Nourbakhsh earned the American Brain Foundation Clinical Research Training Fellowship in MS, the National Multiple Sclerosis Society Sylvia Lawry Clinical Research Fellowship, the Fred Baskin Young Investigator Award, and the Teva Neuroscience Award for Academic Excellence. In 2022, he was named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society. Dr. Nourbakhsh's research training focused on the design and execution of clinical trials and the use of biomarkers in MS. His current research interests include the comparative effectiveness studies of symptomatic and disease-modifying therapies in MS, as well as identifying new pathophysiologic mechanisms and therapeutic targets for MS-related fatigue. Dr. Nourbakhsh is the principal investigator of a randomized, double-blind clinical trial funded by the Department of Defense, which tests whether ketamine could be a treatment for MS fatigue. He has contributed to numerous publications, journal articles, abstracts and posters, and lectures. He is an ad hoc reviewer for Lancet Neurology, Annals of Neurology, Neurology, Neurology: Neuroimmunology and Neuroinflammation, Multiple Sclerosis Journal, and other journals. Dr. Nourbakhsh is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Meningocele.

Dr. Felling is the director of the Johns Hopkins Pediatric Stroke Program and specializes in the evaluation and treatment of children with a wide range of cerebrovascular disorders. With combined training in child neurology and vascular neurology he offers expertise in both the acute diagnosis and treatment of stroke as well as longitudinal management of the neurological consequences of stroke in children. Dr. Felling earned both his M.D. and his Ph.D. in neuroscience at Penn State College of Medicine. He completed residency training in pediatrics at the Children’s Hospital of Philadelphia. He also completed residency training in pediatric neurology and a fellowship in vascular neurology at Johns Hopkins. Dr. Felling's goal is to improve the clinical care of patients through the development of efficient pathways for the rapid evaluation and treatment of children presenting with stroke. He is part of a multidisciplinary team of providers that care for children with cerebrovascular disorders. Clinical research efforts are aimed at improving neurological function in children following stroke and other brain injuries. Dr. Felling is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Stroke, Concussion, Delirium, Thrombectomy, and Endovascular Embolization.

Christopher Jackson is a neurosurgeon who specializes in brain tumors and cerebrovascular disorders, including glioma, meningioma, acoustic neuroma, trigeminal neuralgia, brain metastasis, arteriovenous malformation, and aneurysms. He is the director of the Acoustic Neuroma Center. Dr. Jackson earned his medical degree from the Johns Hopkins University School of Medicine, where he also completed his neurosurgical residency. During his residency, Dr. Jackson was honored with multiple distinctions, including the Frank L. Coulson Jr. Award for Clinical Excellence, the Irving J. Sherman Award for Resident Achievement, the Harvey Cushing Hunterian Research Award, and was elected to Alpha Omega Alpha. Dr. Jackson is an active researcher who has published over 35 peer-reviewed articles on brain tumor and cerebrovascular immunology. His laboratory focuses on how brain tumors evade the immune system and become resistant to immunotherapy. Additionally, Dr. Jackson’s laboratory explores the formation of cerebral aneurysms and inflammatory complications of cerebral aneurysm rupture. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Trigeminal Neuralgia, Meningioma, Dysembryoplastic Neuroepithelial Tumors (DNET), Rhizotomy, and Microvascular Decompression.

Physician assistant Stephanie Garfinkle cares for patients who are diagnosed with a wide range of cerebrovascular disorders, including cerebral aneurysms, arteriovenous malformations, arteriovenous fistulas, subarachnoid hemorrhage, subdural hematomas, cavernous malformations and moyamoya disease. She also cares for patients with other cerebral pathologies, including brain malignancies, acoustic neuromas (vestibular schwannomas) and meningiomas, as well as facial pain disorders such as trigeminal neuralgia. Garfinkle earned her Master of Health Science degree from the Drexel University Physician Assistant Program. Dr. Garfinkle is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. Her top area of expertise is Arteriovenous Malformation.

Dr. Nara Lygia De Macena Sobreira is an assistant professor at the McKusick-Nathans Department of Genetic Medicine at Johns Hopkins University School of Medicine. Her area of expertise is rare Mendelian phenotypes, analysis of next-generation sequencing, and functional testing of candidate causative variants. She earned her M.D. at the University of Pernambuco in Brazil. She finished her Ph.D. in Human Genetics at Johns Hopkins followed by a one-year postdoc also at Johns Hopkins School of Medicine. During her Ph.D., she worked with Dr. David Valle using next-generation sequencing to elucidate the molecular basis of rare Mendelian phenotypes and in 2010 she discovered PTPN11 as the gene responsible for metachondromatosis by using whole-genome sequencing. She completed residencies in clinical genetics at both Universidade Federal de Sao Paulo and Johns Hopkins. Her main clinical and research focus is on identifying the genetic bases of rare phenotypes, mainly, phenotypes associated with cartilage tumors and vascular anomalies (including Ollier disease and Maffucci syndrome), and on understanding the physiopathology of these phenotypes to identify pharmacological strategies to treat them. She has worked extensively on developing strategies to better analyze the variants identified by next-generation sequencing and on novel strategies for data sharing. She participated on the development of PhenoDB, a phenotypic and genomic database, and created PhenoDB Variant Analysis Tool used worldwide. She is also one of the creators of GeneMatcher, VariantMatcher, and one of the co-founders of the Matchmaker Exchange, all intended to share next-generation sequencing data. She has also worked extensively on functional studies that evaluate the possible pathogenic effects of the candidate causative variants. Recent News Articles and Media Coverage Living the Hopkins Mission Honorees, Johns Hopkins Medicine Successes in Characterizing Genes through GeneMatcher with Nara L. M. Sobreira, MD, PhD, Ambry Genetics (April 30, 2018) Enfermedades raras: el desafio es encontrar otros pacientes que tienen el mismo mal, Lun (26 de septiembre de 2019) 2021 Science Writers' Boot Camp, Johns Hopkins Medicine (June 7, 2021) Making the Perfect Match, Johns Hopkins Medicine (February 1, 2020). Dr. De Macena Sobreira is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. Her top areas of expertise are Spondyloepimetaphyseal Dysplasia Strudwick Type, Greenberg Dysplasia, Blepharophimosis, and Early Infantile Epileptic Encephalopathy.

Dr. Lum is a clinically busy vascular surgeon specializing in the open and endovascular treatment of peripheral arterial disease, cartoid artery disease, dialysis access, mesenteric occlusive disease, arterial aneurysms and venous disease. In addition, he has a strong clinical & research interest in thoracic outlet syndrome. Dr Lum also has a Masters in Public Health from the Johns Hopkins School of Public Health. Dr. Lum is rated as an Experienced provider by MediFind in the treatment of Arteriovenous Malformation. His top areas of expertise are Thoracic Outlet Syndrome, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Osteotomy.